NeuPath Health Inc

Research NeuPath Health Inc (NPTH) on Bullrun: market cap CAD 31.34M, P/E 27.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 31.34M; P/E is 27.5.

Peer valuation comparison

Latest P/E is 27.5x versus a Healthcare sector median of 24.46x (12.4% above).

Latest P/E is 27.5x versus a Canada median of 15.58x (76.5% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 87.19M-CAD 717.00KCAD 3.14M19.0%n/aCAD 4.47MCAD 13.14MCAD 20.62M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-28CAD 31.34M27.5n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD.

About NeuPath Health Inc

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is NeuPath Health Inc's market cap?

NeuPath Health Inc's market capitalization is CAD 31.34M.

What is NeuPath Health Inc's P/E ratio?

NeuPath Health Inc's price-to-earnings (P/E) ratio is 27.5.

What does NeuPath Health Inc do?

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.